Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
SINOVAC BIOTECH LTD (SVA) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/15/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"SINOVAC Reports Unaudited First Half of 2023 Financial Results"
05/01/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"SINOVAC Reports Unaudited Second Half of 2022 Financial Results and Files 2022 Annual Report on Form 20-F BEIJING, China, May 1, 2023 /Business Wire/ -- Sinovac Biotech Ltd. , a leading provider of biopharmaceutical products in China, has filed its 2022 annual report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2022. The Company also reported its unaudited financial for the second half and audited financial for full year ended December 31, 2022. Second Half and Full Year 2022 Financial Summary"
04/28/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
02/22/2023 6-K Quarterly results
12/29/2022 6-K Quarterly results
11/04/2022 6-K Quarterly results
06/09/2022 6-K Quarterly results
05/06/2022 6-K Quarterly results
04/29/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Sinovac Biotech Ltd."
02/22/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Third Amendment to Amended and Restated Rights Agreement between Sinovac Biotech Ltd. and Pacific Stock Transfer Company, as Rights Agent",
"Sinovac Amends Shareholder Rights Plan"
12/30/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"SINOVAC Reports Unaudited First Half of 2021 Financial Results"
12/13/2021 6-K Quarterly results
12/10/2021 6-K Quarterly results
12/07/2021 6-K Quarterly results
11/10/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Preliminary Results Show SINOVAC’ s COVID-19 Vaccine Demonstrates Good Safety Profile Among the Pediatric and Adolescent Population BEIJING, China, November 9, 2021 -- SINOVAC Biotech Ltd. , a leading provider of biopharmaceutical products in China, announced new preliminary data on its inactivated COVID-19 vaccine CoronaVac®. The results from statistics analysis under blind status indicated that CoronaVac® is safe for healthy people of different races in the pediatric and adolescent population ranging from 3 to 17 years of age. The multi-center, case-driven, randomized, double-blind, and placebo-controlled phase III study is currently being conducted in South Africa, Chile, Malaysia, and the Philippines. As of October 2021, a total of 2,140 participants ranging from 6 months to 17 years o..."
07/20/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"SINOVAC Receives Approval on Sabin Strain Based Inactivated Polio Vaccine to Support Global Polio Endgame Strategy"
07/20/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"SINOVAC’ s CoronaVac Used on Child Population in China, Good Antibody Levels Observed After Three Months Following Vaccination"
07/12/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"SINOVAC Enters Into Agreement to Supply CoronaVac ® to COVAX"
06/30/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Sinovac Biotech Ltd."
06/02/2021 6-K Quarterly results
04/22/2021 6-K Quarterly results
04/02/2021 6-K Quarterly results
02/22/2021 6-K Quarterly results
02/08/2021 6-K Quarterly results
12/09/2020 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Sinovac Announces Product License for 23-Valent Pneumococcal Polysaccharide Vaccine"
12/07/2020 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Sinovac Secures Approximately $500 Million in Funding for COVID-19 Vaccine Development",
"Sinovac Reports Unaudited Third Quarter 2020 Financial Results"
09/29/2020 6-K Quarterly results
09/23/2020 6-K Quarterly results
09/23/2020 6-K Quarterly results
08/28/2020 6-K Quarterly results
08/26/2020 6-K Quarterly results
07/06/2020 6-K Quarterly results
06/30/2020 6-K Quarterly results
06/24/2020 6-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy